<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig1">
 <label>Fig. 1</label>
 <caption>
  <p>Patient enrollment, study design and different clinical parameters of COVID-19 patients. 
   <bold>a</bold> Summary of recruited COVID-19 patients, including 18 severe patients, 4 critical survivors, and 11 critical non-survivors. 
   <bold>b</bold> Admission days and multi-omics sample collection time of COVID-19 patients. Datasets contained 113 transcriptome, 85 proteome, 85 metabolome, 85 lipidome were collected from 33 patients. Grey bar records time from disease onset to admission by weeks; colored bar records time from admission to outcome-time-point by days. Points represent multi-omics data sampling time. The details of enrolled patients were shown in Additional file 
   <xref rid="MOESM1" ref-type="media">1</xref>: Table S1. 
   <bold>c</bold> The age and gender distribution and comparison of 33 COVID-19 patients. *
   <italic>p</italic> &lt; 0.05. 
   <bold>d</bold> The clinical parameters of COVID-19 patients. 123 clinical data were collected. ****
   <italic>p</italic> &lt; 0.0001, ***
   <italic>p</italic> &lt; 0.001, **
   <italic>p</italic> &lt; 0.01, *
   <italic>p</italic> &lt; 0.05. WBC, white blood cells; Lymph, lymphocyte; NEU, neutrophil; PLT, platelet; Hb, hemoglobin; ALT, alanine transaminase; AST, aspartate aminotransferase; TBIL, total bilirubin; ALB, albumin; GLO, globulin; CRP, C-reactive protein; IL6, interleukin-6; IL10, interleukin-10; IL8, interleukin-10; TNFα, tumor necrosis factor alpha; IL1β, interleukin-1 beta; IL2R, Interleukin-2 receptor; ESR, erythrocyte sedimentation rate; PCT, procalcitonin; D-dimer, fibrin D-dimer
  </p>
 </caption>
 <graphic xlink:href="40635_2021_373_Fig1_HTML" id="MO1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
